Dominick Conde surveyed Federal Circuit precedent regarding its de novo standard of review for claim construction, and looked at the Supreme Court’s consideration of that standard in Teva Pharmaceuticals v. Sandoz, a pending case that likely will settle the multi-decade debate concerning the claim construction standard of review issue.
December 15, 2014 | The New York Law Journal
De Novo Review of Patent Claim Construction
1 min
Related Services
Related Insights
Protecting Your Intellectual Property Rights in Data
Protecting Your Intellectual Property Rights in Data
October 10, 2024
4min
Evidence of Increasing Scams Targeting Trademark Applicants – and What Can Be Done
Evidence of Increasing Scams Targeting Trademark Applicants – and What Can Be Done
October 07, 2024
5min
Patent Term Adjustment and Double Patenting After In re Cellect
Patent Term Adjustment and Double Patenting After In re Cellect
October 2024
1min
Events
Navigating the Complexities of Pharmaceutical Product Labeling: Legal Insights and Best Practices
Navigating the Complexities of Pharmaceutical Product Labeling: Legal Insights and Best Practices
October 22, 2024 Lexology
SupplySide West 2024
SupplySide West 2024
October 30 - 31, 2024 Las Vegas, NV - SupplySide West
Recent News
Ari Markenson Publishes AHLA’s Health Care Law and Policy Acronyms and Terms
Ari Markenson Publishes AHLA’s Health Care Law and Policy Acronyms and Terms
October 11, 2024
1min
Coverage of Richard Wells’ Arrival at Venable
Coverage of Richard Wells’ Arrival at Venable
October 07, 2024
1min
Arlington Newsletter Highlights Three of Venable’s Real Estate Projects
Arlington Newsletter Highlights Three of Venable’s Real Estate Projects
October 04, 2024
1min